earnings
confidence high
sentiment negative
materiality 0.70
Bio-Rad Q4 GAAP operating loss $118.9M; non-GAAP EPS down to $2.51 from $2.90
BIO-RAD LABORATORIES, INC.
2025-FY EPS reported
$27.85
revenue$2,583,200,000
- Q4 GAAP operating loss $118.9M vs income $58.4M YoY; gross margin down 140bps to 49.8%.
- Q4 non-GAAP operating income $83.0M (down 10% YoY); non-GAAP EPS $2.51 vs $2.90.
- Full-year non-GAAP operating income $311.6M vs $331.3M; EPS $9.92 vs $10.31.
- Q4 GAAP net income $720.0M vs $715.8M loss YoY driven by equity investment fair value changes.
- CEO cites geopolitical uncertainty and academic funding pressure; Stilla acquisition integrated.